Ferritin Quantitative Test

PGII Rapid Quantitative Test

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).
Product Detail

Product Specification

Specimen Types
Serum
Specimen Capacity
10μL
Reaction Time
15 min
Sample Capacity
80μL
PGII Detection Range
0.5-200.0ng/mL


Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
biotime PGI Rapid Quantitative Test
PGI Rapid Quantitative Test
Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).
biotime PGI PGII Rapid Quantitative Test
PGI/PGII Rapid Quantitative Test
Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.
Biotime HLC-100 Fully Automated HbA1c Analyzer
HLC-100 Fully Automated HbA1c Analyzer
Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
TT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the total thyroxine 4 (TT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac isoform of TnT (hs-cTnT) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay)
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
biotime CEA Rapid Quantitative Test
CEA Rapid Quantitative Test
Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.
HSV-2 IgG/IgM Rapid Test (Fluorescence Immunoassay)
HSV-2 IgG/IgM Rapid Test (Fluorescence Immunoassay)
The HSV-2 IgG/IgM Rapid Test is an in vitro immunoassay for the qualitative determination of IgG and IgM class antibodies to HSV2 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. The HSV-2 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses2 (HSV-2) infection -For in vitro diagnostic use only. For professional use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact